PDL BioPharma Inc (NASDAQ:PDLI)

2.48
Delayed Data
As of Feb 23
 -0.02 / -0.80%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues444.4M585.0M585.1M239.7M
 
 
 
 
 
Cost of Goods Sold0.00----4.1M
 
 
Depreciation And Amortization5.6M----12.0M
 
 
 
 
Operating ExpensesGross Income438.8M----223.6M
 
 
 
General Expenses29.8M34.9M36.1M44.1M
 
 
 
 
 
Other Operating Expenses0.000.004.0M0.00
 
 
Research And Development------3.8M
 
 
Total Operating Expenses35.4M34.9M40.1M60.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income409.0M550.1M545.0M179.4M
 
 
 
 
 
Extraordinary Credit0.000.006.5M6.5M
 
 
 
Extraordinary Charge0.00-6.1M---60.7M
 
 
 
Interest Expense On Debt24.9M39.2M27.1M20.8M
 
 
 
 
 
Other Expenses-1.5M-3.8M5.8M4.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income401.9M501.3M530.1M109.4M
 
 
 
 
 
Income Taxes-137.3M-179.0M-197.3M-45.7M
 
 
 
 
 
Minority Interest0.000.000.00-53.0K
 
 
Net Income264.5M322.2M332.8M63.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.8M158.2M163.4M163.8M
 
 
 
 
 
Shares To Calculate EPS Diluted159.3M173.1M163.6M164.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.66$1.86$2.03$0.39
 
 
 
 
 
EPS Diluted$1.66$1.86$2.03$0.39